CLYR Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.7/10
Best for: Flat-rate compounded GLP-1 with pricing that does not increase as your dose goes up
CLYR Health is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
CLYR Health is a Florida-based telehealth pharmacy offering compounded GLP-1 weight-loss injections alongside sexual-health, longevity and wellness treatments. It sells compounded semaglutide + B12 from $229/mo and compounded tirzepatide + B12 from $249/mo on flat 'any dose, one price' billing, with 3-month prepay plans that lower the effective rate. Brand Zepbound and oral GLP-1 options are also listed. LegitScript Certified and fulfilled by a named 503A pharmacy.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to CLYR Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
CLYR Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Compounded Semaglutide, Compounded Tirzepatide
- Starting price
- $229/mo (Flat any-dose $229/mo; 3-month prepay $189/mo ($567 billed once))
- What's included
- Medication · Consult
- FDA status
- No FDA warning letter on record
How we scored CLYR Health
Each dimension is scored algorithmically from CLYR Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.8/10At $229/mo, CLYR Health runs about 36% above the $169 median for GLP-1 providers.
Effectiveness25%
8.7/10CLYR Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.0/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
8.6/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-07-16).
Accessibility10%
6.7/10CLYR Health's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.5/10CLYR Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this CLYR Health review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with CLYR Health
We walked CLYR Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete an online health questionnaire so providers can assess eligibility.
- 2A licensed medical provider reviews your profile and, if appropriate, prescribes treatment.
- 3Your prescription ships from a licensed pharmacy to your door in temperature-safe packaging.
- 4Stay connected with the care team for ongoing dosing adjustments and support.
- The public homepage lists flat pricing before intake: compounded semaglutide + B12 at $229/month (any dose, same price) and compounded tirzepatide + B12 starting at $249/month with dose-tiered pricing (Tier 1 from $249, Tier 2 from $399).
- The site states a telehealth consultation is included and there are no hidden fees; it advertises free nationwide shipping and says it ships to 47 states.
- The site displays LegitScript Certified, HIPAA-compliant, licensed US providers, and a 503A state-licensed compounding pharmacy; payments are processed via Stripe.
- An eligibility guarantee / refund if ineligible is referenced, and financing options (Klarna, Affirm, Afterpay) are listed.
- Plans are billed monthly and described as cancel-anytime; a 3-month prepay option lowers the effective monthly rate.
GLP-1 medications CLYR Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Flat any-dose $229/mo; 3-month prepay $189/mo ($567 billed once)
$249/mo standard dose (up to 3mL); 3-month prepay $199/mo; higher dose 4-8mL $349/mo
Ready to get started?
Plans and promotions change often — check CLYR Health's current pricing and active discounts before you decide.
What we like
- Flat 'any dose, one price' billing so the monthly cost does not rise as your dose climbs
- LegitScript Certified with a named 503A pharmacy partner (The Pharmacy Hub, Miami FL) and MD Integrations clinicians
- 3-month prepay drops semaglutide to $189/mo and tirzepatide to $199/mo
Watch-outs
- State availability gated behind intake; not published on the marketing site
- Standing monthly rates ($229-249) run above the cheapest compounded competitors
- Broad catalog (weight loss, sexual health, longevity) rather than a weight-loss specialist
Is CLYR Health worth it? Our verdict
CLYR Health positions itself around one thing: Flat-rate compounded GLP-1 with pricing that does not increase as your dose goes up. It runs $229/month — a premium to the category, so the extras need to justify it.
On top of the prescription itself, CLYR Health points to Compounded Semaglutide, Compounded Tirzepatide, and LegitScript Verified.
How much CLYR Health actually costs
- Compounded semaglutide — $229/month
- Compounded tirzepatide — $249/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so CLYR Health's standing rate sits at the premium end.
For a direct comparison, MadeMed runs semaglutide and tirzepatide from $219/month — worth pricing against CLYR Health before you commit.
Medications: what CLYR Health prescribes
CLYR Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who CLYR Health is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
CLYR Health dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
CLYR Health costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere.
The Bottom Line
CLYR Health is a solid telehealth option with balanced features and pricing.
Ready to start with CLYR Health?
Starting at $229/month. See current pricing and start your free consultation.
CLYR Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider TMates.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this CLYR Health review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See CLYR Health's current pricing
Plans start at $229/month. Start your free consultation to check eligibility and today's price.